Pharmacogenomics as molecular autopsy for forensic toxicology:: Genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases

被引:59
作者
Jin, M
Gock, SB
Jannetto, PJ
Jentzen, JM
Wong, SH
机构
[1] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
[2] Milwaukee Cty Med Examiner Off, Milwaukee, WI USA
关键词
D O I
10.1093/jat/29.7.590
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Pharmacogenomics, the study on genetic contributions to drug action may help in certifying fentanyl toxicity. Fentanyl is used clinically as an adjunct to surgical anesthesia and for chronic pain management. Its toxicity may be partially due to cytochrome P450 (C Y P) 3A4*1B and 3A5*3 variant alleles, resulting in variable fentanyl metabolism. In this study, we examined 25 fentanyl-related deaths (22 Caucasians, 1 African-American, and 2 Native-Americans) from the Milwaukee County Medical Examiner's Office and referral cases. Fentanyl and norfentanyl in postmortem blood samples were analyzed by radioimmunoassay and liquid chromatography-mass spectrometry-mass spectrometry. The samples were then genotyped for CYP3A4*1B and 3A5*3 using Pyrosequencing™. Genotyping showed: 1CYP3A4*1B homozygous and CYP3A5*3 heterozygous, 1 compound CYP3A4*1B and CYP3A5*3 heterozygous, 22 CYP3A4*1B wild type and CYP3A5*3 homozygous, and 1CYP3A5*3 and CYP3A4*1B wild type. CYP variant allelic frequencies of the 25 cases were 6% for CYP3A4*1B and 92% for CYP3A5*3, compared with normal Caucasian CYP3A4*1 B,3-8%, and CYP3A5*3, 85-95%. The mean fentanyl concentration and metabolic ratio of fentanyl to norfentanyl of the 2 cases with CYP3A4*1B a n d CYP3A5*3 variants were 12.8 and 1.4 μ g/L, respectively, lower than those of 22 cases with wild type CYP3A4*1B and CYP3A5*3 homozygous variants, 16.7 and 7.3 μ g/L, respectively. The postmortem/in vivo data provided the first scientific evidence that CYP3A5 is involved in the fentanyl metabolism, and homozygous CYP3A5*3 causes impaired metabolism of fentanyl, and genotyping CYP3A4*1B a n d 3A5*3 variants may help to certify the fentanyl toxicity.
引用
收藏
页码:590 / 598
页数:9
相关论文
共 20 条
  • [1] Duragesic® transdermal patch:: Postmortem tissue distribution of fentanyl in 25 cases
    Anderson, DT
    Muto, JJ
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2000, 24 (07) : 627 - 634
  • [2] Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4
    Ball, SE
    Scatina, JA
    Kao, J
    Ferron, GM
    Fruncillo, R
    Mayer, P
    Weinryb, I
    Guida, M
    Hopkins, PJ
    Warner, N
    Hall, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) : 288 - 294
  • [3] Codeine intoxication associated with ultrarapid CYP2D6 metabolism
    Gasche, Y
    Daali, Y
    Fathi, M
    Chiappe, A
    Cottini, S
    Dayer, P
    Desmeules, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) : 2827 - 2831
  • [4] Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil
    Guitton, J
    Buronfosse, T
    Desage, M
    Lepape, A
    Brazier, JL
    Beaune, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (11) : 1613 - 1619
  • [5] Evidence of significant contribution from CYP3A5 to hepatic drug metabolism
    Huang, WL
    Lin, YS
    McConn, DJ
    Calamia, JC
    Totah, RA
    Isoherranen, N
    Glodowski, M
    Thummel, KE
    [J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1434 - 1445
  • [6] The genetic determinants of the CYP3A5 polymorphism
    Hustert, E
    Haberl, M
    Burk, O
    Wolbold, R
    He, YQ
    Klein, K
    Nuessler, AC
    Neuhaus, P
    Klattig, J
    Eiselt, R
    Koch, I
    Zibat, A
    Brockmöller, J
    Halpert, JR
    Zanger, UM
    Wojnowski, L
    [J]. PHARMACOGENETICS, 2001, 11 (09): : 773 - 779
  • [7] Pharmacogenomics as molecular autopsy for postmortem forensic toxicology:: Genotyping cytochrome p450 2D6 for oxycodone cases
    Jannetto, PJ
    Wong, SH
    Gock, SB
    Laleli-Sahin, E
    Schur, BC
    Jentzen, JM
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2002, 26 (07) : 438 - 447
  • [8] JENTZEN JM, 2003, CLIN FORENSIC TO DEC, P1
  • [9] Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
    Kuehl, P
    Zhang, J
    Lin, Y
    Lamba, J
    Assem, M
    Schuetz, J
    Watkins, PB
    Daly, A
    Wrighton, SA
    Hall, SD
    Maurel, P
    Relling, M
    Brimer, C
    Yasuda, K
    Venkataramanan, R
    Strom, S
    Thummel, K
    Boguski, MS
    Schuetz, E
    [J]. NATURE GENETICS, 2001, 27 (04) : 383 - 391
  • [10] Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases
    Kuhlman, JJ
    McCaulley, R
    Valouch, TJ
    Behonick, GS
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2003, 27 (07) : 499 - 504